Welcome!
OCBC Investment Research (OIR)
Broker's Calls
Brokers’ Digest: SGX, UOB, Marco Polo Marine, Pan-United Corp, Food Empire, PLife REIT, Wilmar
See what the analysts have to say this week.
a day ago
Broker's Calls
OCBC downgrades UOB to ‘hold’ as share price hits new high
Analyst Carmen Lee has kept her target price at $37.50.
7 days ago
Broker's Calls
OCBC’s research head ‘may revise upwards’ banks’ 2025 profit forecasts with fewer Fed cuts expected
Carmen Lee, head of OCBC Investment Research, expects banking analysts to start revising upwards their full-year earnings forecasts for Singapore’s three banks in January after the holiday season.
30 days ago
Broker's Calls
Share buyback and dividend yield to support DBS shares despite lower NIM ahead, says OCBC
Funds previously chasing T-bills may now go into high-yield investments such as DBS.
December 16, 2024
Broker's Calls
Suntec REIT biggest beneficiary from MAS’s ‘looser’ leverage, ICR rules: OCBC
S-REITs are now subject to a single aggregate leverage limit of 50% and a minimum interest coverage ratio (ICR) of 1.5 times.
November 29, 2024
Broker's Calls
Brokers’ Digest: CDL, PropNex, PLife REIT, KIT, SingPost, Grand Banks Yachts, Nio, Frencken, ST Engineering, UOB
Here's what the analysts have to say about these counters this week.
November 28, 2024
F&B sector
Prospects of better FY2025 earnings inspire new ideas for ThaiBev
Following ThaiBev's FY2024 earnings, DBS, OCBC Investment Research, RHB Bank Singapore and PhillipCapital have target prices of 77 cents, 69 cents, 71 cents and 64 cents respectively.
November 28, 2024
Broker's Calls
OCBC downgrades PropNex to 'hold' but raises target price to 96 cents
This comes following the surge in new private home sales in October.
November 26, 2024
Broker's Calls
Brokers’ Digest: AEM, Prime US REIT, Hyphens Pharma, Seatrium, Valuetronics, DFI Retail Group, CDG, Centurion, Sembcorp
Here's what the analysts have to say this week.
November 22, 2024
Broker's Calls
Analysts upgrade calls and TPs on UOB as they look forward to the bank’s capital management plans
The analysts' target prices now range from $37 to $41.
November 12, 2024